These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1919635)

  • 41. Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults: a comparative matched cohort study.
    Fleming DR; Henslee-Downey PJ; Romond EH; Harder EJ; Marciniak E; Munn RK; Messino MJ; Macdonald JS; Bishop M; Rayens MK; Thompson JS; Foon KA
    Bone Marrow Transplant; 1996 Jun; 17(6):917-22. PubMed ID: 8807094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.
    Verdonck LF; Dekker AW; de Gast GC; van Kempen ML; Lokhorst HM; Nieuwenhuis HK
    J Clin Oncol; 1992 Dec; 10(12):1949-54. PubMed ID: 1453209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma.
    Thomson KJ; Morris EC; Bloor A; Cook G; Milligan D; Parker A; Clark F; Yung L; Linch DC; Chakraverty R; Peggs KS; Mackinnon S
    J Clin Oncol; 2009 Jan; 27(3):426-32. PubMed ID: 19064981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.
    Soiffer RJ; Mauch P; Tarbell NJ; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Murrey CI; Coral F; Bosserman L
    Bone Marrow Transplant; 1991 Jan; 7(1):23-33. PubMed ID: 2043874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
    Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
    Bierman PJ; Sweetenham JW; Loberiza FR; Taghipour G; Lazarus HM; Rizzo JD; Schmitz N; van Besien K; Vose JM; Horowitz M; Goldstone A;
    J Clin Oncol; 2003 Oct; 21(20):3744-53. PubMed ID: 12963703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran.
    Alimoghaddam K; Ghaffari H; Foroughi F; Chardouli B; Sanaat Z; Bahar B; Mousavi A; Iravani M; Ghavamzadeh A
    Arch Iran Med; 2006 Apr; 9(2):99-103. PubMed ID: 16649348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
    Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A
    Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.
    Radich JP; Sanders JE; Buckner CD; Martin PJ; Petersen FB; Bensinger W; McDonald GB; Mori M; Schoch G; Hansen JA
    J Clin Oncol; 1993 Feb; 11(2):304-13. PubMed ID: 8426208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J
    Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of bone marrow transplantation in leukaemia and aplastic anaemia.
    Storb R; Santos GW
    Clin Haematol; 1983 Oct; 12(3):721-37. PubMed ID: 6357579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
    Greinix HT; Reiter E; Schulenburg A; Keil F; Lechner K; Fischer G; Rosenmayr A; Leitner G; Kalhs P
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S53-6. PubMed ID: 9916636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful allogeneic bone marrow transplantation for early relapse after autologous bone marrow transplantation in two cases of aggressive high-grade non-Hodgkin's lymphoma.
    Moreau P; Méchinaud F; Mahé B; Le Tortorec S; Rapp MJ; Maisonneuve H; Harousseau JL; Milpied N
    Bone Marrow Transplant; 1996 Sep; 18(3):665-7. PubMed ID: 8879639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allogeneic bone marrow transplantation for low-grade lymphoma.
    van Besien K; Sobocinski KA; Rowlings PA; Murphy SC; Armitage JO; Bishop MR; Chaekal OK; Gale RP; Klein JP; Lazarus HM; McCarthy PL; Raemaekers JM; Reiffers J; Phillips GL; Schattenberg AV; Verdonck LF; Vose JM; Horowitz MM
    Blood; 1998 Sep; 92(5):1832-6. PubMed ID: 9716615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.
    Appelbaum FR; Sullivan KM; Buckner CD; Clift RA; Deeg HJ; Fefer A; Hill R; Mortimer J; Neiman PE; Sanders JE
    J Clin Oncol; 1987 Sep; 5(9):1340-7. PubMed ID: 3305793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma.
    Verdonck LF; Dekker AW; Lokhorst HM; Petersen EJ; Nieuwenhuis HK
    Blood; 1997 Nov; 90(10):4201-5. PubMed ID: 9354692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure.
    Gajewski JL; Ho WG; Feig SA; Hunt L; Kaufman N; Champlin RE
    Transplantation; 1990 Aug; 50(2):244-9. PubMed ID: 2143325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database. Sociét Française de Greffe de Moelle.
    Dhedin N; Giraudier S; Gaulard P; Esperou H; Ifrah N; Michallet M; Milpied N; Rio B; Cahn JY; Molina L; Laporte JL; Guilhot F; Kuentz M
    Br J Haematol; 1999 Oct; 107(1):154-61. PubMed ID: 10520036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.